Last edition
News about "Public Offering"
Cue Biopharma Prices USD 10 Million Public Offering
Cue Biopharma has priced a USD 10 million public offering, with gross proceeds expected to be approximately USD 10 million before underwriting discounts, commissions, and other offering-related expenses.
Public Offering | 20/12/2025 | By News Bureau
Terns Prices Upsized USD 650 Million Public Offering
Terns plans to use the proceeds to advance research and clinical development of its pipeline, including TERN-701, support early commercial launch preparations, and fund working capital and general corporate needs.
Public Offering | 10/12/2025 | By Akanki
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy